WallStreetZenWallStreetZen

NYSE: JNJ
Johnson & Johnson Revenue

OverviewForecastEarningsRevenue
DividendOwnershipStatistics
Johnson & Johnson revenue was $89.33B for the trailing 12 months ending Mar 30, 2025, with -40.6% growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 30, 2025 was $21.9B, down 2.8% from last quarter. For the last reported fiscal year 2024 ending Dec 29, 2024, JNJ annual revenue was $88.8B, with 4.3% growth year-over-year.

JNJ past revenue growth

How has JNJ's revenue growth performed historically?

Company
4.3%
Industry
14.16%
Market
20.27%
JNJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
JNJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
JNJ's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

JNJ revenue history

Current Revenue
$89.3B
Current Earnings
$21.8B
Current Profit Margin
24.4%
JNJ's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when JNJ announces revenue.

JNJ Revenue History By Year

JNJ Yearly RevenueJNJ RevenueJNJ ChangeJNJ Revenue Growth
2024-12-29$88.82B$3.66B+4.30%
2023-12-31$85.16B$5.17B+6.46%
2023-01-01$79.99B$1.25B+1.59%
2022-01-02$78.74B-$3.84B-4.65%
2021-01-03$82.58B$525.00M+0.64%
2019-12-29$82.06B$478.00M+0.59%
2018-12-30$81.58B$5.13B+6.71%
2017-12-31$76.45B$4.56B+6.34%
2017-01-01$71.89B$1.82B+2.59%
2016-01-03$70.07B-$4.26B-5.73%
2014-12-28$74.33B$3.02B+4.23%
2013-12-29$71.31B$4.09B+6.08%
2012-12-30$67.22B$2.19B+3.37%
2012-01-01$65.03B$3.44B+5.59%
2011-01-02$61.59B-$310.00M-0.50%
2010-01-03$61.90B-$1.85B-2.90%
2008-12-28$63.75B$2.65B+4.34%
2007-12-30$61.10B$7.77B+14.57%
2006-12-31$53.32B$2.81B+5.56%
2006-01-01$50.51B$3.17B+6.69%
2005-01-02$47.35B$5.49B+13.10%
2003-12-28$41.86B$5.56B+15.33%
2002-12-29$36.30B$3.98B+12.32%
2001-12-30$32.32B$3.15B+10.78%
2000-12-31$29.17B$1.17B+4.16%
1999-12-30$28.01BN/AN/A

1 of 2

Johnson & Johnson Revenue FAQ

What was JNJ's revenue last quarter?

On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q1 2025 revenue of $21.89 billion up 2.39% year over year. In the same quarter last year, Johnson & Johnson's revenue was $21.38 billion.

What was Johnson & Johnson's revenue in 2024?

Johnson & Johnson's annual revenue for the twelve months ending Dec 29, 2024 was $88.82 billion, a 4.3% increase year over year.

How much does Johnson & Johnson make in a day?

Based on Johnson & Johnson annual revenue for the past five years, JNJ makes an average of $227,558,356.16 per day.

What was Johnson & Johnson's annual revenue growth in the past year?

As of Q2 2025, Johnson & Johnson's revenue has grown 4.3% year over year. This is 9.86 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 14.16%. Johnson & Johnson's revenue in the past year totaled $89.33 billion.

How much does Johnson & Johnson make in a year?

Johnson & Johnson's revenue by year for the past five years is:
  • Johnson & Johnson's revenue for the twelve months ending Dec 29, 2024 was $88.82 billion, a 4.3% increase year over year.
  • Johnson & Johnson's annual revenue for Dec 31, 2023 was $85.16 billion, a 6.46% increase from 2023.
  • Johnson & Johnson's annual revenue for 2023 was $79.99 billion, a 1.59% increase from 2022.
  • Johnson & Johnson's annual revenue for 2022 was $78.74 billion, a 4.65% decrease from 2021.
  • Johnson & Johnson's annual revenue for 2021 was $82.58 billion, a 0.64% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.